Tag: aphria rating

Cronos Group (CRON) reported its third-quarter earnings on November 12. The company missed analysts' revenue and EBITDA estimates for the quarter.

For the last few months, there's been weakness in the cannabis sector. Investors were hoping for Canopy Growth and Aurora Cannabis to bring some relief.

This year, Aurora Cannabis (ACB) has lost 30.5% of its stock value as of Thursday. Should you start to consider buying the stock? Jim Cramer doesn't think so.

Cantor Fitzgerald initiated coverage of six cannabis companies on Monday. Analyst Pablo Zuanic noted that several cannabis stocks have bottomed out.

For Aurora Cannabis (ACB), Canaccord lowered its target price from 13.50 Canadian dollars to 8.00 Canadian dollars with a “speculative buy” rating.

On Tuesday, CIBC initiated coverage on OrganiGram with an “outperformer” rating and a target price of 9.0 Canadian dollars.